Contraception clinical trials at UCLA
3 in progress, 1 open to eligible people
Injectable DMAU for Male Contraception in Healthy Male Volunteers (CCN015)
open to eligible males ages 18-50
This is a Phase I multicenter, double-blind, single dose, dose-ranging study, in healthy men to evaluate the safety and tolerability, pharmacokinetics and pharmacodynamics of Dimethandrolone Undecanoate (DMAU) administered as an intramuscular or subcutaneous injection.
Torrance, California and other locations
Contraceptive Efficacy and Safety of Etonogestrel (ENG) Implant Beyond 3 Years of Use (MK-8415-060)
Sorry, in progress, not accepting new patients
The primary purpose of this study is to assess the efficacy and safety of the etonogestrel (ENG) contraceptive implant during participants' fourth and fifth years of use when used as the only method of contraception. The ENG implant is currently approved for a 3-year duration, and this study aims to confirm available evidence suggesting that the ENG implant remains highly effective when used up to 5 years.
Los Angeles, California and other locations
Daily Application of Nestorone® (NES) and Testosterone (T) Combination Gel for Male Contraception
Sorry, in progress, not accepting new patients
The long term objective is to develop a gel to be used as a male contraceptive.
Torrance, California and other locations
Our lead scientists for Contraception research studies include Christina Wang, MD.
Last updated: